Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Rischke, Hans Christian ^a   Schäfer, Arnd O ^a   Nestle, Ursula ^a   Volegova Neher, Natalja ^a   Henne, Karl ^a   Benz, Matthias R ^b   Schultze Seemann, Wolfgang ^a   Langer, Mathias ^a   Grosu, Anca L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dynamic contrast enhanced MRI; Gross tumor volume; Prostate cancer; PSA recurrence; Salvage radiotherapy

Indexed keywords

GADOBENATE DIMEGLUMINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROSTATE CANCER; PROSTATECTOMY; RECURRENT CANCER; SALVAGE THERAPY; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84868239836     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-185     Document Type: Article

References (25)

1. Choo R, Hruby G, Hong J, Bahk E, Hong E, Danjoux C, et al. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 2002, 53(2):269-276. Epub 2002/05/23. PubMed PMID: 12023129, 10.1016/S0360-3016(02)02730-X, 12023129.
2. Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 2003, 61(2):365-369. 01/02/25. PubMed PMID: 12597949, 10.1016/S0090-4295(02)02268-9, 12597949.
3. Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery--what we have learned and where we are going. J Urol 1999, 162(2):293-306. Epub 1999/07/20. PubMed PMID: 10411025, 10.1016/S0022-5347(05)68543-6, 10411025.
4. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003, 169(2):517-523. 10.1097/01.ju.0000045749.90353.c7., 12544300.
5. Sella T, Schwartz LH, Swindle PW, Onyebuchi CN, Scardino PT, Scher HI, et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 2004, 231(2):379-385. 10.1148/radiol.2312030011., 15064390.
6. Silverman JM, Krebs TL. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol 1997, 168(2):379-385. Epub 1997/02/01. PubMed PMID: 9016212.
7. Casciani E, Polettini E, Carmenini E, Floriani I, Masselli G, Bertini L, et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR Am J Roentgenol 2008, 190(5):1187-1192. 10.2214/AJR.07.3032., 18430830.
8. Sciarra A, Panebianco V, Salciccia S, Osimani M, Lisi D, Ciccariello M, et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008, 3:589-600.
9. Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging--initial experience. Radiology 2004, 233(3):709-715. 10.1148/radiol.2333032098., 15498903.
10. Futterer JJ, Engelbrecht MR, Huisman HJ, Jager GJ, Hulsbergen-van De Kaa CA, Witjes JA, et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 2005, 237(2):541-549. 10.1148/radiol.2372041724., 16244263.
11. Futterer JJ, Heijmink SW, Scheenen TW, Jager GJ, de Kaa CA H-V, Witjes JA, et al. Prostate cancer: local staging at 3-T endorectal MR imaging--early experience. Radiology 2006, 238(1):184-191. 10.1148/radiol.2381041832., 16304091.
12. Bernard JR, Buskirk SJ, Heckman MG, Diehl NN, Ko SJ, Macdonald OK, et al. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. Int J Radiat Oncol Biol Phys 2010, 76(3):735-740. 10.1016/j.ijrobp.2009.02.049., 19464818.
13. King CR, Kapp DS. Radiotherapy after prostatectomy: is the evidence for dose escalation out there?. Int J Radiat Oncol Biol Phys 2008, 71(2):346-350. 10.1016/j.ijrobp.2007.10.008., 18234451.
14. King CR, Spiotto MT. mproved outcomes with higher doses for salvage radiotherapy after prostatectomy. Int J Radiat Oncol Biol Phys 2008, 71(1):23-27. 10.1016/j.ijrobp.2007.09.047., 18207668.
15. Miralbell R, Vees H, Lozano J, Khan H, Molla M, Hidalgo A, et al. Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. Int J Radiat Oncol Biol Phys 2007, 67(2):356-361. 10.1016/j.ijrobp.2006.08.079., 17236961.
16. Ohri N, Dicker AP, Trabulsi EJ, Showalter TN. Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling. Eur J Cancer 2011,
17. Allen SD, Thompson A, Sohaib SA. The normal post-surgical anatomy of the male pelvis following radical prostatectomy as assessed by magnetic resonance imaging. Eur Radiol 2008, 18(6):1281-1291. 10.1007/s00330-008-0867-3., 18270715.
18. Cirillo S, Petracchini M, Scotti L, Gallo T, Macera A, Bona MC, et al. Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol 2009, 19(3):761-769. 10.1007/s00330-008-1174-8., 18825386.
19. Wasserman NF, Kapoor DA, Hildebrandt WC, Zhang G, Born KM, Eppel SM, et al. Transrectal US in evaluation of patients after radical prostatectomy. Part I. Normal postoperative anatomy. Radiology 1992, 185(2):361-366. Epub 1992/11/01. PubMed PMID: 1410339.
20. Wasserman NF, Reddy PK. Use of transrectal ultrasound in follow-up of postradical prostatectomy. Urology 1993, 41(1 Suppl):52-56. Epub 1993/01/01. PubMed PMID: 8420096.
21. McLaughlin PW, Evans C, Feng M, Narayana V. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys 2010, 76(2):369-378. 10.1016/j.ijrobp.2009.02.019., 19515511.
22. McLaughlin PW, Troyer S, Berri S, Narayana V, Meirowitz A, Roberson PL, et al. Functional anatomy of the prostate: implications for treatment planning. Int J Radiat Oncol Biol Phys 2005, 63(2):479-491. 10.1016/j.ijrobp.2005.02.036., 16168840.
23. Leventis AK, Shariat SF, Slawin KM. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology 2001, 219(2):432-439. Epub 2001/04/27. PubMed PMID: 11323468.
24. Ornstein DK, Colberg JW, Virgo KS, Chan D, Johnson ET, Oh J, et al. Evaluation and management of men whose radical prostatectomies failed: results of an international survey. Urology 1998, 52(6):1047-1054. Epub 1998/12/04. PubMed PMID: 9836553, 10.1016/S0090-4295(98)00403-8, 9836553.
25. Saleem MD, Sanders H, Abu El Naser M, El-Galley R. Factors predicting cancer detection in biopsy of the prostatic fossa after radical prostatectomy. Urology 1998, 51(2):283-286. Epub 1998/03/12. PubMed PMID: 9495712, 10.1016/S0090-4295(97)00509-8, 9495712.